Xtandi 40 MG capsule 120S
Ended Awarded
- Contract number
- SPE2DX25F6AEN
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $101,771
Award facts
- Contract value 100% obligated
- $101,771.28 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $101,771.28 for 120 units of Xtandi 40 mg capsules. The contract, awarded on August 27, 2025, with an ultimate completion date of August 28, 2025, represents a direct supply of this oncology medication to support federal healthcare operations. The award was issued under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency valued at $499,999,999 and valid through November 2026, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. No set-aside designation was utilized for this particular delivery order.
This delivery order supports the Department of Defense's Medical Supply Chain operations, with performance based in Park Ridge, Illinois. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical distribution network, leveraging its woman-owned small business status to compete effectively in federal procurement markets. The company's portfolio demonstrates consistent delivery of prescription medications, including oncology treatments and specialty pharmaceuticals, to military and federal healthcare facilities nationwide. The firm fixed-price structure of this delivery order ensures cost predictability for the government while maintaining supply chain continuity for essential pharmaceutical products.
Quick answers
Who was awarded contract SPE2DX25F6AEN?
SPE2DX25F6AEN was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 27, 2025.
How much is contract SPE2DX25F6AEN worth?
The government has obligated $101,771 on SPE2DX25F6AEN.
Is contract SPE2DX25F6AEN an order under another contract?
Yes. SPE2DX25F6AEN is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AEN competed?
The extent of competition for SPE2DX25F6AEN was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award